🇦🇺 Australia · Lyrebird Health — Australian AI Clinical Documentation

Status: 🟩 COMPLETE 🟦 LIVING Section: 10 — AI and LLMs

VendorLyrebird Health
Country/origin🇦🇺 Australia (Melbourne; founded 2022)
Recommended for AUS?✅ Yes — Australian-built; Australian data storage; AHPRA-aware design
Privacy summaryAustralian data residency; SOC 2 Type II; Privacy Act compliant; HIPAA capable; clinical-grade data handling; consent-driven design
Free tier✅ Free for individual clinicians (limited consultations)
Paid tiersPro (~$79 AUD/month) per clinician; clinic and enterprise tiers
First released2022 (founded); growing Australian clinical adoption 2023-2026
Last reviewedJune 2026
Official sitehttps://lyrebirdhealth.com

What it is

Lyrebird Health is another Australian-built AI clinical documentation tool — a direct competitor to Heidi Health (see heidi-health) in the rapidly growing Australian clinical AI market. Founded in Melbourne in 2022, Lyrebird is named after the Australian native bird famed for its remarkable ability to mimic sounds — appropriate for a tool that listens to clinical conversations and transforms them into documentation.

Like Heidi, Lyrebird:

  • Listens to clinical consultations (with patient consent)
  • Generates structured clinical notes in real-time
  • Supports Australian clinical workflows and templates
  • Integrates with major Australian practice management systems
  • Stores Australian patient data in Australia

Distinctive aspects:

  • Strong focus on user experience and clinician workflow
  • Some clinicians prefer Lyrebird’s interface; others prefer Heidi’s
  • Active development with frequent feature releases
  • Growing community of Australian clinician users

Why Australia has multiple clinical AI options

The emergence of multiple Australian clinical documentation AI tools (Heidi, Lyrebird, Pulse, others) reflects:

  • Genuine market need — Australian clinical workforce shortages and burnout
  • Competitive Australian AI talent pool
  • Australian healthcare’s openness to clinical AI adoption
  • Regulatory clarity — TGA framework allows clinical documentation tools as software (not medical devices, in most cases)
  • Strong unit economics — Australian clinicians benefit substantially from time savings

For Australian clinicians: this competitive market is good news — multiple quality options, ongoing innovation, competitive pricing.


How Lyrebird compares to Heidi Health

The two leading Australian clinical AI documentation tools:

AspectLyrebird HealthHeidi Health
Founded20222019
OriginMelbourneMelbourne
Australian data
AHPRA-aware design
Practice management integration✅ Major systems✅ Major systems
Template varietyGrowingEstablished
User interfaceModern, streamlinedEstablished, comprehensive
PricingFree tier + ~$79 AUD/monthFree tier + ~$99 AUD/month
User baseSmaller, growing rapidlyLarger, established
SpecialisationsAll specialtiesMajor specialties + niches

Real-world choice between them: Most Australian clinicians try both via free tiers and choose based on UX preference, specific feature fit, and pricing. Neither is objectively better — they’re different products solving the same problem.


What you’d use it for

Same as Heidi Health:

  • GP consultations
  • Allied health sessions
  • Specialist consultations
  • Referral letters
  • Progress notes
  • Care plans
  • Discharge summaries

How to access (Australian clinicians)

  1. Go to https://lyrebirdhealth.com
  2. Register with your AHPRA registration number
  3. Verify your professional credentials
  4. Use the web or mobile app
  5. Integrate with your practice management system

Like Heidi, patient consent for AI recording is required and is the clinician’s responsibility.


What it costs

PlanPriceFeatures
Free$0Limited monthly consultations
Pro~$79 AUD/monthUnlimited consultations
ClinicCustomMulti-clinician practices
EnterpriseCustomHospital systems; SSO

Slightly cheaper than Heidi at the Pro level (~99 AUD), though feature parity varies.


  • Always required. Recording without consent breaches Privacy Act, state law, and AHPRA codes.
  • Verbal consent at consultation start, documented in notes
  • Some patients will decline — respect; have non-AI workflow available

Australian data residency

  • Australian patient data stored in Australia
  • Encrypted in transit and at rest
  • Patient information not used to train AI models without explicit institutional consent

Australian regulatory considerations

  • Australian Privacy Act 1988 applies
  • AHPRA professional standards apply
  • State-specific health records laws (Victoria, NSW, etc.)
  • TGA — Lyrebird is generally classified as software (not medical device) for documentation use

AHPRA professional considerations

  • Clinical responsibility remains with the clinician
  • Notes must accurately reflect consultation
  • Patient’s right to refuse AI use preserved

Workflow integration

Lyrebird integrates with Australian practice management systems:

  • Best Practice (BP Premier)
  • MedicalDirector (Pracsoft)
  • Genie
  • Cliniko
  • Splose
  • Halaxy
  • And others

Like Heidi, the clinician review-and-save step is preserved — Lyrebird produces drafts; clinicians approve.


Templates and customisation

Lyrebird offers Australian-specific templates:

  • GP consultations (standard, long, mental health)
  • Care plans (GPMP, TCA, MHCP)
  • Referral letters
  • Specialist templates
  • Allied health templates

Customisation allows clinicians to refine templates to their preferred format.


Gotchas (same as Heidi)

  • Consent is non-negotiable. Document patient consent for every recording.
  • Notes still require clinician review. AI generates a draft; clinician owns final note.
  • Accents and rapid speech. Performs well on Australian English; complex cases may have lower accuracy.
  • Privacy in shared spaces. Consider physical environment when using AI listening.
  • Patient explanations. Have a clear answer for patients asking how AI use works.
  • System integration setup time. First-time integration with practice management takes time.
  • Don’t over-rely. AI captures words; nuance and body language remain clinician’s responsibility.
  • Verify Australian indemnity coverage — confirm your medical defence organisation covers AI documentation use.

Why having competition matters

The presence of Heidi, Lyrebird, Pulse, and other Australian clinical AI tools means:

  • Competitive pricing for clinicians
  • Ongoing feature development across products
  • No vendor lock-in — clinicians can switch
  • Australian innovation supported by Australian customer base
  • Diverse solutions for diverse clinical contexts

For Australian healthcare overall: this is a healthy market. Australian clinicians benefit.


The Australian clinical AI market

As of mid-2026:

  • Heidi Health: Largest user base; established
  • Lyrebird Health: Growing rapidly; competitive on UX
  • Pulse: Newer entrant; specific clinical focus
  • International alternatives (Suki AI, DAX Copilot, Augmedix) — less Australian-specific

Australian clinicians have genuine choice. This is exciting and rapidly evolving.


See also


Sources

  • Lyrebird Health official: lyrebirdhealth.com
  • AHPRA Code of Conduct
  • RACGP guidance on AI in general practice
  • Australian Doctor and Healthcare IT News coverage of Australian clinical AI
  • Comparison reviews between Heidi and Lyrebird (clinician community discussions)
  • Privacy Act 1988 and APPs
  • TGA software classification guidance